3,325 trials (keyword fallback)
Jugular Venous Flow
Primary: Internal Jugular Venous Flow — 0.04; 0.4; 0.04; 0.21 cm2
Intravenous Access
Primary: First Attempt Success Rate — 17; 11 Participants
Infection
Primary: Total Number of Central Line Associated Blood Stream Infections (CLABSI) — 113; 84; 123; 109 infections
Catheter Infection · Catheter Thrombosis · Catheter Complications
Primary: Upper Extremity CR-UEVT — 7; 11 Participants
Difficult Peripheral IV Access
Primary: Time to Successful Placement of a Functioning USGIV/IO — 163.7; 67.3 seconds
Venous Thromboembolism
Primary: Number of Participants With Postoperative VTE Within 48 Hours After Surgery — 5; 3 participants — p=0.72
Vascular Access Device Complications
Primary: Percent Eligible Patients That Agreed to Participate — 80 percentage of eligible patients agreed t
Kidney Diseases
Primary: Feasibility- Eligibility for Randomization — 54 Participants
PICC · Central Venous Catheter · Central Line
Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271
Varicose Ulcer
Primary: Identification of Biomarkers Predictive of Ulcer Healing. — 9 Number of biomarkers
Obesity · Vascular Diseases
Primary: Successful First Attempt Peripheral Venous Cannulation — 96 participants
Asthma · Communication
Primary: Score of Asthma Control Questionnaire — -0.48; -0.27 score on a scale
Blood Pressure
Primary: Standardized Ratio as a Percentage Between Mean IOP and Mean Arterial Pressure — 34.5; 40.5; 40.1 percentage of IO pressure to cuff pressu
Fibromyalgia
Primary: Pain at Rest Difference Score Pre-intervention and Post Intervention — 0.38; -0.74; -0.47 units on a scale
Upper Extremity Deep Vein Thrombosis · Central Venous Catheter Thrombosis · Cancer
Primary: Primary Feasibility Outcome - Number of Participants Recruited Per Month — 7.5; 2.0 Average enrolment rate/month/site